CV 8-K 2026-09-28
CapsoVision, Inc (CV) 8-K dated 2026-09-28 — accession 0001378325-26-000045.
CapsoVision, Inc (CV) is a medical devices company listed on US.
CapsoVision, Inc filed a 8-K on 2026-09-28. Accession 0001378325-26-000045.
This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported CV revenue for 2025-12-31 was $13.6M. Net income was -$25.3M. Revenue was up 15.3% from 2024-12-31 to 2025-12-31. CV currently screens at market cap $359.2M.
Not investment advice. The CV SEC hub lists recent forms. The stock page is the research view.